{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T14:08:55Z","timestamp":1785506935280,"version":"3.56.0"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T00:00:00Z","timestamp":1572480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002332","name":"Semmelweis Egyetem","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2019.01061","type":"journal-article","created":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T16:10:18Z","timestamp":1572538218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["The Role of Genetic Testing in the Clinical Practice and Research of Early-Onset Parkinsonian Disorders in a Hungarian Cohort: Increasing Challenge in Genetic Counselling, Improving Chances in Stratification for Clinical Trials"],"prefix":"10.3389","volume":"10","author":[{"given":"Anett","family":"Ill\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00f3ra","family":"Csab\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Grosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Balicza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e1s","family":"G\u00e9zsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Moln\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e1ta","family":"Bencsik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"G\u00e1l","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Kliv\u00e9nyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Judit","family":"Molnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,31]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/hmg\/8.4.567","article-title":"A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French parkinson\u2019s disease genetics study group and the european consortium on genetic susceptibility in Parkinson\u2019s disease","volume":"8","author":"Abbas","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/mds.25833","article-title":"A Novel DCTN1 mutation with late-onset parkinsonism and frontotemporal atrophy","volume":"29","author":"Araki","year":"2014","journal-title":"Mov. Disord."},{"key":"B3","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/mgg3.267","article-title":"A molecular analysis of the GBA gene in caucasian South Africans with parkinson\u2019s disease","volume":"5","author":"Barkhuizen","year":"2017","journal-title":"Mol. Genet. genomic Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00702-003-0079-6","article-title":"Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson?s disease","volume":"111","author":"Benbunan","year":"2004","journal-title":"J. Neural Transm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13024-016-0097-0","article-title":"Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson\u2019s Disease","volume":"11","author":"Benitez","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/mds.23617","article-title":"Novel mutations in siblings with later-onset PLA2G6-associated neurodegeneration (PLAN)","volume":"26","author":"Bower","year":"2011","journal-title":"Mov. Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2174\/1389203717666160311122152","article-title":"Other proteins involved in parkinson\u2019s disease and related disorders","volume":"18","author":"Cardona","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"key":"B9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archneur.63.4.548","article-title":"Case-control study of the parkin gene in early-onset parkinson disease","volume":"63","author":"Clark","year":"2006","journal-title":"Arch Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.22117","article-title":"Locus-specific mutation databases for neurodegenerative brain diseases","volume":"33","author":"Cruts","year":"2012","journal-title":"Hum. Mutat."},{"key":"B11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10048-011-0302-9","article-title":"Breakpoint mapping of 13 large parkin deletions\/duplications reveals an exon 4 deletion and an exon 7 duplication as founder mutations","volume":"12","author":"Elfferich","year":"2011","journal-title":"Neurogenetics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"536","DOI":"10.3389\/fneur.2018.00536","article-title":"Heterozygous PLA2G6 mutation leads to iron accumulation within basal ganglia and parkinson\u2019s disease","volume":"9","author":"Ferese","year":"2018","journal-title":"Front. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JPD-140507","article-title":"Usefulness of genetic testing in PD and PD trials: a balanced review","volume":"5","author":"Gasser","year":"2015","journal-title":"J. Parkinsons. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/mds.26064","article-title":"DNAJC13 genetic variants in parkinsonism","volume":"30","author":"Gustavsson","year":"2015","journal-title":"Mov. Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/mds.20234","article-title":"Distribution, type and origin of Parkin mutations: review and case studies","volume":"19","author":"Hedrich","year":"2004","journal-title":"Mov. Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/ana.74","article-title":"Positron emission tomographic analysis of the nigrostriatal dopaminergic system in familial Parkinsonism associated with mutations in the Parkin gene","volume":"49","author":"Hilker","year":"2001","journal-title":"Ann. Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1007\/s10571-018-0587-4","article-title":"Parkinson disease from mendelian forms to genetic susceptibility: new molecular insights into the neurodegeneration process","volume":"38","author":"Karimi-Moghadam","year":"2018","journal-title":"Cell. Mol. Neurobiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1097\/GIM.0b013e3182217a3a","article-title":"American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variants","volume":"13","author":"Kearney","year":"2011","journal-title":"Genet. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1136\/JNNP-2017-317234","article-title":"Oligogenic genetic variation of neurodegenerative disease genes in 980 postmortem human brains","volume":"89","author":"Keogh","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B20","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/ana.10417","article-title":"Clinical and subclinical dopaminergic dysfunction in PARK6-linked parkinsonism: An18F-dopa PET study","volume":"52","author":"Khan","year":"2002","journal-title":"Ann. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10545-005-7495-8","article-title":"Movement disorders: classifications","volume":"28","author":"Klein","year":"2005","journal-title":"J. Inherit. Metab. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ncpneuro0126","article-title":"The genetics of Parkinson disease: implications for neurological care","volume":"2","author":"Klein","year":"2006","journal-title":"Nat. Clin. Pract. Neurol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"D862","DOI":"10.1093\/nar\/gkv1222","article-title":"ClinVar: public archive of interpretations of clinically relevant variants","volume":"44","author":"Landrum","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.mcp.2016.11.001","article-title":"Genetics of Parkinson\u2019s disease","volume":"30","author":"Lill","year":"2016","journal-title":"Mol. Cell. Probes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"E2393","DOI":"10.1002\/humu.22376","article-title":"dbNSFP v2.0: A database of human non-synonymous SNVs and their functional predictions and annotations","volume":"34","author":"Liu","year":"2013","journal-title":"Hum. Mutat."},{"key":"B26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ajmg.b.32012","article-title":"PLA2G6 mutations in PARK14-linked young-onset parkinsonism and sporadic Parkinson\u2019s disease","author":"Lu","year":"2012","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5483","DOI":"10.1093\/hmg\/ddw348","article-title":"Additional rare variant analysis in Parkinson\u2019s disease cases with and without known pathogenic mutations: evidence for oligogenic inheritance","volume":"25","author":"Lubbe","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","article-title":"The genetic landscape of Parkinson\u2019s disease","volume":"174","author":"Lunati","year":"2018","journal-title":"Rev. Neurol. (Paris)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163980","article-title":"Brain connectivity changes in autosomal recessive parkinson disease: a model for the sporadic form","volume":"11","author":"Makovac","year":"2016","journal-title":"PLoS One"},{"key":"B30","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/humu.20719","article-title":"PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum","volume":"29","author":"Marongiu","year":"2008","journal-title":"Hum. Mutat."},{"key":"B31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.cellimm.2007.02.013","article-title":"Establishing a neurological-psychiatric biobank: banking, informatics, ethics","volume":"244","author":"Molnar","year":"2006","journal-title":"Cell. Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1212\/01.wnl.0000278115.50741.4e","article-title":"LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8","volume":"69","author":"Nichols","year":"2007","journal-title":"Neurol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000044","article-title":"Overlap between Parkinson disease and Alzheimer disease in ABCA7 functional variants","volume":"2","author":"Nuytemans","year":"2016","journal-title":"Neurol. Genet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/humu.21277","article-title":"Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: A mutation update","volume":"31","author":"Nuytemans","year":"2010","journal-title":"Hum. Mutat."},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-130192","article-title":"LRRK2: Cause, risk, and mechanism","volume":"3","author":"Pais\u00e1n-Ruiz","year":"2013","journal-title":"J. Parkinsons. Dis."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020988","article-title":"Copy number variation in familial parkinson disease","volume":"6","author":"Pankratz","year":"2011","journal-title":"PLoS One"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/brain\/awg136","article-title":"Parkin mutations are frequent in patients with isolated early-onset parkinsonism","volume":"126","author":"Periquet","year":"2003","journal-title":"Brain"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"B39","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11910-017-0780-8","article-title":"New genes causing hereditary parkinson\u2019s disease or parkinsonism","volume":"17","author":"Puschmann","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/brain\/aww261","article-title":"Heterozygous PINK1 p.G411S increases risk of Parkinson\u2019s disease via a dominant-negative mechanism","volume":"140","author":"Puschmann","year":"2017","journal-title":"Brain"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/mds.25994","article-title":"Phenotypic variability of PINK1 expression: 12 Years\u2019 clinical follow-up of two Italian families","volume":"29","author":"Ricciardi","year":"2014","journal-title":"Mov. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s: from familial to sporadic disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1073\/pnas.1616152114","article-title":"Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models","volume":"114","author":"Sardi","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1080\/00207454.2016.1255612","article-title":"Second mutation in PARK2 is absent in patients with sporadic Parkinson\u2019s disease and heterozygous exonic deletions\/duplications in parkin gene","volume":"127","author":"Shulskaya","year":"2017","journal-title":"Int. J. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3389\/fnagi.2018.00136","article-title":"Whole-exome sequencing in searching for new variants associated with the development of parkinson\u2019s disease","volume":"10","author":"Shulskaya","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"B47","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/hmg\/ddw405","article-title":"Properties of human disease genes and the role of genes linked to Mendelian disorders in complex disease aetiology","volume":"26","author":"Spataro","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"B48","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/S1353-8020(13)70011-7","article-title":"Genetics of Parkinson\u2019s disease: the yield","volume":"20","author":"Spatola","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From fastq data to high-confidence variant calls: the genome analysis toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Current Protocols in Bioinf"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1093\/hmg\/ddt570","article-title":"DNAJC13 mutations in Parkinson disease","volume":"23","author":"Vilari\u00f1o-G\u00fcell","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.neulet.2006.09.080","article-title":"A common A340T variant in PINK1 gene associated with late-onset Parkinson\u2019s disease in Chinese","volume":"410","author":"Wang","year":"2006","journal-title":"Neurosci. Lett."},{"key":"B52","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/ajmg.10525","article-title":"Complex relationship between Parkin mutations and Parkinson disease","volume":"114","author":"West","year":"2002","journal-title":"Am. J. Med. Genet. - Neuropsychiatr. Genet."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/3136415","article-title":"A Meta-Analysis of GBA -related clinical symptoms in parkinson\u2019s disease","volume":"2018","author":"Zhang","year":"2018","journal-title":"Parkinsons. Dis."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.995","article-title":"Ceruloplasmin in Parkinson\u2019s disease and the nonmotor symptoms","volume":"8","author":"Zhao","year":"2018","journal-title":"Brain Behav."},{"key":"B55","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/j.1468-1331.2010.03164.x","article-title":"Confirmation of LRRK2 S1647T variant as a risk factor for Parkinson\u2019s disease in Southern China","volume":"18","author":"Zheng","year":"2011","journal-title":"Eur. J. Neurol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.01061\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,31]],"date-time":"2019-10-31T16:10:22Z","timestamp":1572538222000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.01061\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,31]]},"references-count":55,"alternative-id":["10.3389\/fgene.2019.01061"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2019.01061","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,31]]},"article-number":"1061"}}